Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States
Article in Postgraduate Medicine (May 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies
Article in Cardiovascular Diabetology (March 2024)
Self-identified prescriber tendencies in sodium-glucose cotransporter-2 inhibitor outpatient prescribing
Article in Journal of the American Pharmacists Association (March 2024)